2023), stimulating insulin secretion, suppressing glucagon release, regulating appetite, and increasing energy expenditure (Fig
Learn it once, apply it everywhere
Tirzepatide is a dual-action drug that targets both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
They can usually be managed with the help of other types of medication
Autoimmune diseases are chronic inflammatory conditions, and the National Institute of Environmental Health Sciences recognizes more than 80 distinct autoimmune disorders, including Graves disease, multiple sclerosis (MS), systemic lupus erythematosus (SLE), type 1 diabetes mellitus (T1D), and rheumatoid arthritis (RA) [2]